NCT02402127

Brief Summary

The purpose of this study is to measure the coefficient of friction of three silicone hydrogel, daily disposable contact lenses after 16 hours of wear.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 30, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

September 2, 2016

Completed
Last Updated

September 2, 2016

Status Verified

July 1, 2016

Enrollment Period

2 months

First QC Date

March 25, 2015

Results QC Date

July 25, 2016

Last Update Submit

July 25, 2016

Conditions

Keywords

Contact lensesLubricity

Outcome Measures

Primary Outcomes (1)

  • Average Coefficient of Friction of Worn Lenses at 16 Hours

    Worn contact lenses were removed from the participant's eye and the coefficient of friction was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.

    Day 1, Hour 16, each product

Secondary Outcomes (1)

  • Average Coefficient of Friction of Unworn Lenses

    Day 1 (each product)

Study Arms (6)

TruEye, MyDay, clariti 1day

OTHER

Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

TruEye, clariti 1day, MyDay

OTHER

Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

MyDay, TruEye, clariti 1day

OTHER

Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

MyDay, clariti 1day, TruEye

OTHER

Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

Clariti 1day, TruEye, MyDay

OTHER

Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

Clariti 1day, MyDay, TruEye

OTHER

Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).

Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses

Interventions

Silicone hydrogel contact lenses for daily disposable wear

Also known as: 1-DAY ACUVUE® TruEye® (TruEye)
Clariti 1day, MyDay, TruEyeClariti 1day, TruEye, MyDayMyDay, TruEye, clariti 1dayMyDay, clariti 1day, TruEyeTruEye, MyDay, clariti 1dayTruEye, clariti 1day, MyDay

Silicone hydrogel contact lenses for daily disposable wear

Also known as: MyDay™
Clariti 1day, MyDay, TruEyeClariti 1day, TruEye, MyDayMyDay, TruEye, clariti 1dayMyDay, clariti 1day, TruEyeTruEye, MyDay, clariti 1dayTruEye, clariti 1day, MyDay

Silicone hydrogel contact lenses for daily disposable wear

Also known as: clariti® 1day
Clariti 1day, MyDay, TruEyeClariti 1day, TruEye, MyDayMyDay, TruEye, clariti 1dayMyDay, clariti 1day, TruEyeTruEye, MyDay, clariti 1dayTruEye, clariti 1day, MyDay

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must sign an informed consent form.
  • Soft contact lens wearer (both eyes).
  • Willing to wear study lenses at least 16 waking hours and attend all study visits.

You may not qualify if:

  • Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated.
  • Use of artificial tears and rewetting drops during the study.
  • Monocular (only 1 eye with functional vision) or fit with only 1 lens.
  • History of herpetic keratitis, ocular surgery, or irregular cornea.
  • Pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Global Medical Affairs Franchise Head, Vision Care
Organization
Alcon Research, Ltd.

Study Officials

  • Clinical Manager, Vision Care, Global Medical Affairs

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2015

First Posted

March 30, 2015

Study Start

May 1, 2015

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

September 2, 2016

Results First Posted

September 2, 2016

Record last verified: 2016-07